These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32021407)

  • 1. Relationship Between Pain Reduction and Improvement in Health-Related Quality of Life in Patients with Knee Pain Due to Osteoarthritis Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study.
    Enomoto H; Fujikoshi S; Ogawa K; Tsuji T; Tanaka S
    J Pain Res; 2020; 13():181-191. PubMed ID: 32021407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of duloxetine by prior NSAID use in the treatment of chronic osteoarthritis knee pain: A post hoc subgroup analysis of a randomized, placebo-controlled, phase 3 study in Japan.
    Enomoto H; Fujikoshi S; Tsuji T; Sasaki N; Tokuoka H; Uchio Y
    J Orthop Sci; 2018 Nov; 23(6):1019-1026. PubMed ID: 30126675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study.
    Uchio Y; Enomoto H; Ishida M; Tsuji T; Ochiai T; Konno S
    J Pain Res; 2018; 11():1391-1403. PubMed ID: 30104894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Pain Alleviation and Disease-specific Health-related Quality of Life Measures in Patients With Chronic Low Back Pain Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study.
    Enomoto H; Sasaki N; Fujikoshi S; Yoshikawa A; Tsuji T; Takeshita K
    J Am Acad Orthop Surg Glob Res Rev; 2019 Nov; 3(11):. PubMed ID: 31875196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to duloxetine in patients with knee pain due to osteoarthritis: an exploratory post hoc analysis of a Japanese Phase III randomized study.
    Itoh N; Tsuji T; Ishida M; Ochiai T; Konno S; Uchio Y
    J Pain Res; 2018; 11():2603-2616. PubMed ID: 30464579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis.
    Uchio Y; Enomoto H; Alev L; Kato Y; Ishihara H; Tsuji T; Ochiai T; Konno S
    J Pain Res; 2018; 11():809-821. PubMed ID: 29713194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data.
    Wang G; Bi L; Li X; Li Z; Zhao D; Chen J; He D; Wang CN; Wu T; Dueñas H; Skljarevski V; Yue L
    BMC Musculoskelet Disord; 2019 Apr; 20(1):174. PubMed ID: 31010413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of duloxetine in patients with knee osteoarthritis or chronic low back pain with early pain reduction: An exploratory post-hoc analysis of Japanese phase 3, 1-year extension studies.
    Itoh N; Uchio Y; Tsuji T; Ishida M; Ochiai T; Konno S
    J Orthop Sci; 2022 May; 27(3):717-724. PubMed ID: 33958268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
    Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
    Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of duloxetine for multisite pain in patients with knee pain due to osteoarthritis: An exploratory post hoc analysis of a Japanese phase 3 randomized study.
    Itoh N; Tsuji T; Ishida M; Ochiai T; Konno S; Uchio Y
    J Orthop Sci; 2021 Jan; 26(1):141-148. PubMed ID: 32245696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical meaningfulness of duloxetine's effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase 3 randomized trial.
    Yue L; Luo S; Wang Y; Wang CN; Dueñas HJ; Skljarevski V
    Open Access Rheumatol; 2019; 11():67-76. PubMed ID: 30962729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Chinese Western Ontario and McMaster Universities Osteoarthritis Index in Patients From Mainland China With Osteoarthritis of the Knee.
    Symonds T; Hughes B; Liao S; Ang Q; Bellamy N
    Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1553-60. PubMed ID: 26018634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Updated Systematic Review and Meta-analysis of Duloxetine for Knee Osteoarthritis Pain.
    Chen B; Duan J; Wen S; Pang J; Zhang M; Zhan H; Zheng Y
    Clin J Pain; 2021 Nov; 37(11):852-862. PubMed ID: 34483232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of the Intermittent and Constant Osteoarthritis Pain (ICOAP) scale in a trial of duloxetine for treatment of osteoarthritis knee pain.
    Risser RC; Hochberg MC; Gaynor PJ; D'Souza DN; Frakes EP
    Osteoarthritis Cartilage; 2013 May; 21(5):691-4. PubMed ID: 23485934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to duloxetine in chronic low back pain: exploratory post hoc analysis of a Japanese Phase III randomized study.
    Tsuji T; Itoh N; Ishida M; Ochiai T; Konno S
    J Pain Res; 2017; 10():2157-2168. PubMed ID: 28919811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Treatment Effect of Triamcinolone Acetonide Extended-Release in Patients with Concordant Baseline Pain Scores on the Average Daily Pain and Western Ontario and McMaster Universities Osteoarthritis Index Pain Scales.
    Ross E; Katz NP; Conaghan PG; Kivitz A; Turk DC; Spitzer AI; Jones DG; Lanier RK; Cinar A; Lufkin J; Kelley SD
    Pain Ther; 2022 Mar; 11(1):289-302. PubMed ID: 34791634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial.
    Frakes EP; Risser RC; Ball TD; Hochberg MC; Wohlreich MM
    Curr Med Res Opin; 2011 Dec; 27(12):2361-72. PubMed ID: 22017192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
    Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
    J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial.
    Peloso PM; Moore RA; Chen WJ; Lin HY; Gates DF; Straus WL; Popmihajlov Z
    Scand J Pain; 2016 Oct; 13():175-181. PubMed ID: 28850528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.